Attached files
| file | filename |
|---|---|
| 10-K - JINZANGHUANG TIBET PHARMACEUTICALS, INC. FORM 10-K JUNE 30, 2009 - JINZANGHUANG TIBET PHARMACEUTICALS, INC. | jzhg10k20090630.htm |
| EX-31.2 - RULE 13A-14(A) CERTIFICATION - CFO - JINZANGHUANG TIBET PHARMACEUTICALS, INC. | jzhg10k20090630ex31-2.htm |
| EX-31.1 - RULE 13A-14(A) CERTIFICATION ? CEO - JINZANGHUANG TIBET PHARMACEUTICALS, INC. | jzhg10k20090630ex31-1.htm |
EXHIBIT 32: Rule 13a-14(b)
Certifications
The
undersigned officers certify that this report fully complies with the
requirements of Section 13(a) of the Securities Exchange Act of 1934, and that
the information contained in the report fairly presents, in all material
respects, the financial condition and results of operations of Jinzanghuang
Tibet Pharmaceuticals, Inc.
A signed
original of this written statement required by Section 906 has been provided to
Jinzanghuang Tibet Pharmaceuticals, Inc. and will be retained by Jinzanghuang
Tibet Pharmaceuticals, Inc. and furnished to the Securities and Exchange
Commission or its staff upon request.
|
October
12, 2009
|
/s/ Xue
Bangyi
|
|
Xue
Bangyi (Chief Executive Officer)
|
|
|
October
12, 2009
|
/s/ Zeng
Yiling
|
|
Zeng
Yiling (Chief Financial Officer)
|